StockData
P3 Health Partners Inc. logo

P3 Health Partners Inc. (PIII) stock

PIIINasdaqServices-Health ServicesFiscal year ends December 31Also trades as PIIIW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$2.19−0.22 (-9.13%)

Close on Nov 17, 2026Market cap $15.90MP/E –Yield –

Earnings

P3 Health Partners's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$396.00M
+14.7% on a year earlier
EPS, Q3 FY2026
$0.07
-$9.67 a year earlier
Latest guidance
Lowered
Nov 9, 2026 · 5 items

Quarterly results

Revenue and earnings per share from each of P3 Health Partners's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 9, 2026after the close$396.00M+14.7%$0.07Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026after the close$386.00M+8.5%–Release
Q1 FY2026ended Mar 31, 2026May 14, 2026after the close$386.00M+3.4%$0.32Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026after the close$384.80M+3.8%–Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025after the close$345.30M-4.6%-$9.67Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close$355.80M-6.2%-$6.23Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close$373.20M-3.9%-$6.28Release
Q4 FY2024ended Dec 31, 2024Mar 27, 2025after the close$370.70M+6.9%–Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024after the close$362.10M+25.6%–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024after the close$379.20M+16.5%-$0.15Release
Q1 FY2024ended Mar 31, 2024May 8, 2024after the close$388.50M+28.6%-$0.16Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

P3 Health Partners's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total RevenuesGAAPFY2026$1.53B – $1.60B–NewNov 9, 2026
Total Revenues (in millions)FY2026$1.50B – $1.65B–NewMay 14, 2026
Adjusted EBITDAnon-GAAPFY2026$90.00M – $110.00M–NewNov 9, 2026
Adjusted EBITDA (1)(3) (in millions)non-GAAPFY2026$20.00M – $60.00M–NewMay 14, 2026
At-risk MembersFY2026102,000 – 106,000–NewNov 9, 2026
At-risk MembersFY2026103,000 – 110,000–NewMay 14, 2026
Medical Marginnon-GAAPFY2026$260.00M – $300.00M–NewNov 9, 2026
Medical Margin (1)(3) (in millions)non-GAAPFY2026$190.00M – $230.00M–NewMay 14, 2026
Medical Margin (1)(3) PMPMnon-GAAPFY2026149 – 180–NewMay 14, 2026
Medical Margin PMPMnon-GAAPFY2026$210 – $240–LoweredNov 9, 2026

Guidance vs results

The last range P3 Health Partners gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$1.40B – $1.45B$1.46BΣ4QAbove range

Guidance history

Every forecast P3 Health Partners put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 9, 2026Adjusted EBITDAFY2026$90.00M – $110.00MNew
Nov 9, 2026Medical Margin PMPMFY2026$210 – $240Lowered
Nov 9, 2026Medical MarginFY2026$260.00M – $300.00MNew
Nov 9, 2026At-risk MembersFY2026102,000 – 106,000New
Nov 9, 2026Total RevenuesFY2026$1.53B – $1.60BNew
May 14, 2026Adjusted EBITDA (1)(3) (in millions)FY2026$20.00M – $60.00MNew
May 14, 2026Medical Margin (1)(3) (in millions)FY2026$190.00M – $230.00MNew
May 14, 2026Medical Margin (1)(3) PMPMFY2026149 – 180New
May 14, 2026At-risk MembersFY2026103,000 – 110,000New
May 14, 2026Total Revenues (in millions)FY2026$1.50B – $1.65BNew
Nov 13, 2025Adjusted EBITDAFY2025-$110.00M – -$95.00MNew
Nov 13, 2025At-risk MembersFY2025112,000 – 117,000New
Nov 13, 2025Medical MarginFY2025$67.00M – $82.00MNew
Nov 13, 2025Medical Margin PMPMFY2025$48 – $59Lowered
Nov 13, 2025Total RevenuesFY2025$1.40B – $1.45BNew
Aug 14, 2025Adjusted EBITDAFY2025-$69.00M – -$39.00MLowered
Aug 14, 2025Medical MarginFY2025$124.00M – $154.00MNew
Aug 14, 2025Medical Margin PMPMFY2025$90 – $111Lowered
Aug 14, 2025At-risk MembersFY2025109,000 – 119,000Reaffirmed
Aug 14, 2025Total RevenuesFY2025$1.35B – $1.50BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases P3 Health Partners filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. Results
  5. Results
  6. Results
  7. Results
  8. Results
  9. Results
  10. Update
  11. Results
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?